UK markets closed

BNY Mellon Strategic Municipal Bond Fund, Inc. (DSM)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
5.71+0.05 (+0.88%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 279.77M
Enterprise value N/A
Trailing P/E 29.79
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)27.81
Price/book (mrq)0.87
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 3-0.88%
S&P500 52-week change 322.43%
52-week high 35.91
52-week low 34.69
50-day moving average 35.73
200-day moving average 35.49

Share statistics

Avg vol (3-month) 3134.2k
Avg vol (10-day) 3129.16k
Shares outstanding 549.43M
Implied shares outstanding 649.43M
Float 8N/A
% held by insiders 10.00%
% held by institutions 142.81%
Shares short (15 Apr 2024) 424k
Short ratio (15 Apr 2024) 40.19
Short % of float (15 Apr 2024) 40.05%
Short % of shares outstanding (15 Apr 2024) 40.05%
Shares short (prior month 15 Mar 2024) 435.13k

Dividends & splits

Forward annual dividend rate 40.22
Forward annual dividend yield 43.96%
Trailing annual dividend rate 30.25
Trailing annual dividend yield 34.38%
5-year average dividend yield 45.03
Payout ratio 4128.42%
Dividend date 328 Feb 2019
Ex-dividend date 413 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Nov 2023
Most-recent quarter (mrq)30 Nov 2023

Profitability

Profit margin 44.51%
Operating margin (ttm)86.85%

Management effectiveness

Return on assets (ttm)2.25%
Return on equity (ttm)2.62%

Income statement

Revenue (ttm)20.43M
Revenue per share (ttm)0.41
Quarterly revenue growth (yoy)-3.20%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)7.34M
Diluted EPS (ttm)0.19
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)722.87k
Total cash per share (mrq)0.01
Total debt (mrq)113.56M
Total debt/equity (mrq)35.51%
Current ratio (mrq)0.15
Book value per share (mrq)6.47

Cash flow statement

Operating cash flow (ttm)15.7M
Levered free cash flow (ttm)59.66M